Karyopharm Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.12

+0.17 (+8.72%)

As of Aug 15, 2:16 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +2,217.9% upside

Low Target $31.72

Average Target $49.14

High Target $61.64

Current Price $2.12

Current
$2.12

Target
$49.14

$31.72 $49.14 avg $61.64

Scenario Analysis

Bear Case

$31.72

1,396.2%

Low target

Base Case

$49.14

+2,217.9%

Avg target

Bull Case

$61.64

+2,807.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$10.99

-80.7% from high

52-Week Low

$1.80

+17.8% from low

Target vs 52W High

$49.14

+347.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%